Molecular basis of weak D phenotypes

被引:300
作者
Wagner, FF
Gassner, C
Müller, TH
Schönitzer, D
Schunter, F
Flegel, WA
机构
[1] Univ Ulm Klinikum, Abt Transfus Med, D-89081 Ulm, Germany
[2] Inst Ulm, DRK Blutspendedienst Baden Wurttemberg, D-89081 Ulm, Germany
[3] Zent Inst Bluttransfus & Immunol Abt, Innsbruck, Austria
[4] Inst Oldenvurg, DRK Blutspendedienst Niedersachsen Oldenburg, Oldenburg, Germany
关键词
D O I
10.1182/blood.V93.1.385.401k19_385_393
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A Rhesus D (RhD) red blood cell phenotype with a weak expression of the D antigen occurs in 0.2% to 1% of whites and is called weak D, formerly D-u. Red blood cells of weak D phenotype have a much reduced number of presumably complete D antigens that were repeatedly reported to carry the amino acid sequence of the regular RhD protein. The molecular cause of weak D was unknown. To evaluate the molecular cause of weak D, we devised a method to sequence all 10 RHD exons, Among weak D samples, we found a total of 16 different molecular weak D types plus two alleles characteristic of partial D. The amino acid substitutions of weak D types were located in intracellular and transmembraneous protein segments and clustered in four regions of the protein (amino acid positions 2 to 13, around 149, 179 to 225, and 267 to 397). Based on sequencing, polymerase chain reaction-restriction fragment length polymorphism and polymerase chain reaction using sequence-specific priming, none of 161 weak D samples investigated showed a normal RHD exon sequence. We concluded, that in contrast to the current published dogma most, if not all, weak D phenotypes carry altered RhD proteins, suggesting a causal relationship. Our results showed means to specifically detect and to classify weak D, The genotyping of weak D may guide Rhesus negative transfusion policy for such molecular weak D types that were prone to develop anti-D, (C) 1999 by The American Society of Hematology.
引用
收藏
页码:385 / 393
页数:9
相关论文
共 62 条
[1]   A PROPOSAL TO STANDARDIZE TERMINOLOGY FOR WEAK D-ANTIGEN [J].
AGRE, PC ;
DAVIES, DM ;
ISSITT, PD ;
LAMY, BM ;
SCHMIDT, PJ ;
TREACY, M ;
VENGELENTYLER, V .
TRANSFUSION, 1992, 32 (01) :86-87
[2]  
[Anonymous], 1984, The Human Blood Groups
[3]  
ARCE MA, 1993, BLOOD, V82, P651
[4]   Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification [J].
Aubin, JT ;
Kim, CL ;
Mouro, I ;
Colin, Y ;
Bignozzi, C ;
Brossard, Y ;
Cartron, JP .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 98 (02) :356-364
[5]   Molecular basis of the D variant phenotypes DNU and D-II allows localization of critical amino acids required for expression of Rh D epitopes epD3, 4 and 9 to the sixth external domain of the Rh D protein [J].
Avent, ND ;
Jones, JW ;
Liu, W ;
Scott, ML ;
Voak, D ;
Flegel, WA ;
Wagner, FF ;
Green, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1997, 97 (02) :366-371
[6]   Evidence of genetic diversity underlying Rh D-, weak D (D-u), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene [J].
Avent, ND ;
Martin, PG ;
ArmstrongFisher, SS ;
Liu, W ;
Finning, KM ;
Maddocks, D ;
Urbaniak, SJ .
BLOOD, 1997, 89 (07) :2568-2577
[7]  
AVENT ND, 1992, J BIOL CHEM, V267, P15134
[8]  
Beckers E. A. M., 1995, Transfusion (Bethesda), V35, p50S
[9]   Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene [J].
Beckers, EAM ;
Faas, BHW ;
Ligthart, P ;
Overbeeke, MAM ;
vondemBorne, AEGK ;
vanderSchoot, CE ;
vanRhenen, DJ .
TRANSFUSION, 1997, 37 (06) :616-623
[10]   Rh DNA - Coordinator's report [J].
Cartron, JP .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 1996, 3 (06) :491-495